Jürgen Jäger

Learn More
Today, in silico studies and trial simulations already complement experimental approaches in pharmaceutical R&D and have become indispensable tools for decision making and communication with regulatory agencies. While biology is multiscale by nature, project work, and software tools usually focus on isolated aspects of drug action, such as pharmacokinetics(More)
Addressing climate change vulnerability requires an understanding of both the level of climate impacts and the capacity of the exposed population to cope. This study developed a methodology for allowing users to explore vulnerability to changes in ecosystem services as a result of climatic and socioeconomic changes. It focuses on the vulnerability of Europe(More)
  • 1